Galmed Pharmaceuticals Ltd.
EOCN · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Sidransky David: Form 3
Insider disclosure · Filed · Report period 18 Mar 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001595353 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- EOCN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- C/O Meitar Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan, Israel, 5250608
- Incorporated in
- Israel
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields